PUBLISHED ON: May 7, 2012 | Duration: 6 min, 57 sec
Deven Choksey, MD of KR Choksey Securities feels that pharma companies can be good, defensive bets currently. He likes Cipla in the pharma pack. "Ranbaxy is attractive at current valuations," he said in a chat with NDTV Profit's Prashant Nair.
